Latest Healthcare Research Reports

Tag: influenza diagnostic market growth

  • Unlocking Opportunities in the Influenza Diagnostic Market: Key Trends, Market Growth, and Forecast Insights

    Unlocking Opportunities in the Influenza Diagnostic Market: Key Trends, Market Growth, and Forecast Insights

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theInfluenza Diagnostic Market?

    The demand for rapid diagnostic tests is expected to drive the growth of the influenza diagnostic market. Rapid diagnostic tests provide quick and accurate results, and their use is increasing across healthcare settings. For example, the Australian Institute of Health and Welfare reported an increase in diagnostic imaging services from 28.4 million in 2021-22 to 29.7 million in 2022-23. The growing demand for rapid diagnostic tests is contributing to the growth of the influenza diagnostic market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    #How Will the CAGR of the Influenza Diagnostic Market Influence Its Overall Growth by 2034?

    The influenza diagnostic market has grown strongly in recent years. It is expected to increase from $2.73 billion in 2024 to $2.89 billion in 2025, at a CAGR of 5.9%. This growth is driven by the growth of e-commerce, labor shortages, automation and productivity improvements, supply chain optimization, rising labor costs, and government support for automation and robotics.

    The influenza diagnostic market is expected to see strong growth, reaching $4.01 billion by 2029 at a CAGR of 8.5%. This growth is driven by customization and scalability, environmental and sustainability goals, improving operational efficiency, and modern supply chain dynamics. Major trends include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, AI-driven decision making, collaborative robots, and advancements in robotic technology.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

    Which Cutting-Edge Market Trends Are Expected to Drive theInfluenza Diagnostic Market’s Growth?

    Companies in the influenza diagnostic market are developing innovative products such as the Lucira COVID-19 & Flu Home Test, which allows simultaneous, rapid detection of both COVID-19 and the flu. For instance, in February 2023, Pfizer Inc. received approval for this at-home test kit that can detect influenza A and B and SARS-CoV-2 from self-collected nasal swab samples in about 30 minutes.

    Who Are the Key Market Players Influencing the Growth of the Corn and Influenza Diagnostic Industry?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Key Market Segments Comprise the Influenza Diagnostic Market and Drive Its Revenue Growth?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Which Regions Are Emerging as Leaders in the Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2025, By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Analyzing the Future of Influenza Diagnostic Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the influenza diagnostic market right now?

    There has been substantial growth in the influenza diagnostic market size in recent years. An expansion from $2.73 billion in 2024 to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%, is anticipated. The growth experienced in the historic period is largely due to the boost in e-commerce, labor shortages, automation and productivity, optimization of supply chains, increasing labor costs, and government backing for automation and robotics.

    How fast Is the influenza diagnostic market expected to grow, and what’s its future value?

    Expectations are high for significant expansion in the influenza diagnostic market in the upcoming years. With a compound annual growth rate (CAGR) of 8.5%, the market is anticipated to reach $4.01 billion in 2029. Factors contributing to this predicted growth during the forecast period include the need for customization and scalability, environmental and sustainability targets, efficiency enhancement requirements, and the necessity to conform to the demands of contemporary supply chain dynamics. The forecast period is also likely to witness key trends such as integration of cutting-edge technology, robot-assisted picking and packing, autonomous mobile robots, on-the-spot data and analytics, AI-powered decision making, cooperative robots, and progress in robotic technology.

    Get your influenza diagnostic market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What are the leading drivers of growth in the influenza diagnostic market?

    The influenza diagnostic market is projected to be propelled forward by the rise of rapid diagnostic tests. These medical tools or procedures are used to establish or dispel the presence of a condition or disease. With an increasing demand for quick and accurate outcomes in healthcare, Rapid diagnostic tests (RDTs) are on the rise. Rapid influenza diagnostic tests (RIDTs) are capable of identifying influenza viral antigens within 10-15 minutes with a moderate sensitivity of 50-70%. For example, the Australian Institute of Health and Welfare, an Australian government agency that focuses on health and disease information, reported in July 2024 that diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Therefore, rapid diagnostic tests are playing a significant part in the expansion of the influenza diagnostic market.

    What are the key segments defining the influenza diagnostic market?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    Who are the key players steering the development of the influenza diagnostic market?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    What emerging trends are influencing the growth of the influenza diagnostic market?

    In the influenza diagnostic market, prominent businesses are introducing state-of-the-art products like the Lucira COVID-19 & Flu Home Test, designed for quick qualitative detection. Its application involves a single-use at-home test kit, providing results from self-obtained nasal swabs in roughly half an hour. An example is Pfizer Inc., a pharmaceutical corporation based in the United States, which secured approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify both influenza A and B, usually referred to as the flu, and SARS-CoV-2, which is the virus causing COVID-19.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

    Which regions are most influential in expanding the influenza diagnostic market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Influenza Diagnostic Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead

    Influenza Diagnostic Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Influenza Diagnostic Market’s Growth Rate Evolve Over the Forecast Period to 2034?

    There has been substantial growth in the influenza diagnostic market size in recent years. An expansion from $2.73 billion in 2024 to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%, is anticipated. The growth experienced in the historic period is largely due to the boost in e-commerce, labor shortages, automation and productivity, optimization of supply chains, increasing labor costs, and government backing for automation and robotics.

    Expectations are high for significant expansion in the influenza diagnostic market in the upcoming years. With a compound annual growth rate (CAGR) of 8.5%, the market is anticipated to reach $4.01 billion in 2029. Factors contributing to this predicted growth during the forecast period include the need for customization and scalability, environmental and sustainability targets, efficiency enhancement requirements, and the necessity to conform to the demands of contemporary supply chain dynamics. The forecast period is also likely to witness key trends such as integration of cutting-edge technology, robot-assisted picking and packing, autonomous mobile robots, on-the-spot data and analytics, AI-powered decision making, cooperative robots, and progress in robotic technology.

    How Are the key drivers expanding the growth of the Influenza Diagnostic Market?

    The influenza diagnostic market is projected to be propelled forward by the rise of rapid diagnostic tests. These medical tools or procedures are used to establish or dispel the presence of a condition or disease. With an increasing demand for quick and accurate outcomes in healthcare, Rapid diagnostic tests (RDTs) are on the rise. Rapid influenza diagnostic tests (RIDTs) are capable of identifying influenza viral antigens within 10-15 minutes with a moderate sensitivity of 50-70%. For example, the Australian Institute of Health and Welfare, an Australian government agency that focuses on health and disease information, reported in July 2024 that diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Therefore, rapid diagnostic tests are playing a significant part in the expansion of the influenza diagnostic market.

    Get Your Free Sample of the Global Influenza Diagnostic Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    Who Are the Influential Players Reshaping the Influenza Diagnostic Market Landscape?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    What Current Trends in the Influenza Diagnostic Market Should Industry Players Pay Attention To?

    In the influenza diagnostic market, prominent businesses are introducing state-of-the-art products like the Lucira COVID-19 & Flu Home Test, designed for quick qualitative detection. Its application involves a single-use at-home test kit, providing results from self-obtained nasal swabs in roughly half an hour. An example is Pfizer Inc., a pharmaceutical corporation based in the United States, which secured approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify both influenza A and B, usually referred to as the flu, and SARS-CoV-2, which is the virus causing COVID-19.

    Get Instant Access to the Global Influenza Diagnostic Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    How Are the Key Segments of the Influenza Diagnostic Market Impacting Its Expansion and Revenue Streams?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Which Geographic Locations Are Critical to the Growth of the Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Key Characteristics That Define the Influenza Diagnostic Market?

    Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

    Browse Through More Similar Reports By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Outlook of the Global Influenza Diagnostic Market 2024-2033: Size and Growth Rate Predictions

    Future Outlook of the Global Influenza Diagnostic Market 2024-2033: Size and Growth Rate Predictions

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Influenza Diagnostic Global Market Report 2024 Market from 2024 to 2033?

    The influenza diagnostic market has shown strong growth in recent years. It will increase from $2.59 billion in 2023 to $2.79 billion in 2024, with a CAGR of 7.6%. The growth is attributed to public health concerns, technological advancements, antiviral medications, and pandemic preparedness.

    The influenza diagnostic market is expected to experience strong growth, reaching $3.68 billion by 2028 at a CAGR of 7.2%. Factors driving this growth include seasonal influenza, point-of-care testing, and remote testing. Trends include molecular diagnostics, antigen-based tests, and automation.

    Claim Your Free Sample of the Global Influenza Diagnostic Global Market Report 2024 Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What Key Factors Are Fueling the Growth of the Influenza Diagnostic Global Market Report 2024 Market?

    The growth of the influenza diagnostic market is anticipated to be driven by the increasing use of rapid diagnostic tests. These tests help confirm or rule out medical conditions by detecting viral antigens in a short timeframe of 10-15 minutes, with moderate sensitivity (50-70%). For example, the CDC reported that from September 2020 to May 2021, 0.2% of respiratory samples tested in the U.S. were positive for the influenza virus. Therefore, the widespread adoption of rapid diagnostic tests is expected to significantly impact the influenza diagnostic market.

    What Are the Major Segments of the Influenza Diagnostic Global Market Report 2024 Market?

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    What New Trends Are Transforming the Influenza Diagnostic Global Market Report 2024 Market?

    Leading companies in the influenza diagnostic market are developing innovative products such as the Lucira COVID-19 & Flu Home Test for rapid simultaneous detection of flu and COVID-19. In February 2023, Pfizer Inc. received approval for the Lucira by Pfizer COVID-19 & Flu Home Test, which provides results from self-collected nasal swabs within 30 minutes, detecting both influenza A and B and SARS-CoV-2.

    Order Now for Fast Delivery of Your Influenza Diagnostic Global Market Report 2024 Market Report!

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Regions Are Driving Growth in the Influenza Diagnostic Global Market Report 2024 Market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Influenza Diagnostic Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the influenza diagnostic global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Influenza Diagnostic Global Market Report 2024 Market Include

    1. Influenza Diagnostic Global Market Report 2024 Market Executive Summary

    2. Influenza Diagnostic Global Market Report 2024 Market Segments

    3. Influenza Diagnostic Global Market Report 2024 Market Size And Template Market Growth Rate

    4. Key Influenza Diagnostic Global Market Report 2024 Market Trends

    5. Major Influenza Diagnostic Global Market Report 2024 Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Influenza Diagnostic Global Market Report 2024 Market

    26. Top Influenza Diagnostic Global Market Report 2024 Companies

    27. Influenza Diagnostic Global Market Report 2024 Market Opportunities And Strategies

    28. Influenza Diagnostic Global Market Report 2024 Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Molecular Biology Enzymes & Kits & Reagents Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/molecular-biology-enzymes-and-kits-and-reagents-global-market-report

    Global Molecular Diagnostics Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends And Drivers In The Influenza Diagnostic Market 2024

    Key Trends And Drivers In The Influenza Diagnostic Market 2024

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    The influenza diagnostic market is poised for substantial growth in the coming years, with an expected surge to $3.68 billion in 2028, boasting a Compound Annual Growth Rate (CAGR) of 7.2%. This growth is attributed to factors such as the prevalence of seasonal influenza, the rise of point-of-care testing, the adoption of remote and home testing, and the integration of digital health solutions.

    Rapid Diagnostic Tests: Propelling Market Growth

    Understanding Diagnostic Tests
    Diagnostic tests play a crucial role in confirming or ruling out various conditions and diseases. Rapid influenza diagnostic tests (RIDTs) are set to be a significant driver in the influenza diagnostic market. These tests can swiftly detect influenza viral antigens within 10-15 minutes, offering moderate sensitivity (50-70%). According to the Centers for Disease Control and Prevention (CDC), during September 2020 to May 2021 in the United States, 0.2% of respiratory specimens tested were positive for an influenza virus, highlighting the importance of rapid diagnostic tests.

    Key Market Players
    Major players in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, and Hologic Inc., among others. These companies are at the forefront of developing and providing innovative diagnostic solutions to meet the growing demand for influenza testing.

    Simultaneous Detection: A Breakthrough in Diagnosis
    Innovative Products Leading the Way
    Major companies in the influenza diagnostic market are focusing on innovation, introducing breakthrough products like the Lucira COVID-19 & Flu Home Test. This at-home test kit allows simultaneous qualitative detection of influenza A and B (commonly known as the flu) and SARS-CoV-2 (the virus causing COVID-19). Pfizer Inc. received approval for this test in February 2023, highlighting the industry’s commitment to providing convenient and comprehensive diagnostic solutions.

    Read More On The Influenza Diagnostic Market Report 2024 – https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Strength in Integration
    The Lucira COVID-19 & Flu Home Test exemplifies the integration of diagnostic capabilities. With results available in approximately 30 minutes from self-collected nasal swab samples, this test showcases the industry’s dedication to offering rapid and reliable diagnostic solutions for both influenza and COVID-19.

    Thermo Fisher’s Strategic Move: Mesa Biotech Acquisition
    Strengthening Diagnostic Capabilities
    In February 2021, Thermo Fisher Scientific Inc. made a strategic move by acquiring Mesa Biotech, Inc., an infectious disease diagnostic company. This acquisition aims to enhance Thermo Fisher’s manufacturing volume, achieve cost efficiencies, and expedite the delivery of diagnostics to the market on a larger scale. Such strategic partnerships and acquisitions contribute to the overall advancement and growth of the influenza diagnostic market.

    Market Segmentation: Navigating the Landscape
    Understanding Diagnostic Tests
    The influenza diagnostic market is intricately segmented based on traditional diagnostic tests and molecular diagnostic tests. Traditional diagnostic tests include Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological assays, and other traditional diagnostic tests. On the other hand, molecular diagnostic tests encompass Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop-Mediated Isothermal Based Amplification Assays, and other molecular diagnostic tests.

    End User Perspectives
    End-user segments in the influenza diagnostic market include Hospitals and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, and Other End Users. Understanding these segments is crucial for comprehending the diverse applications and demands within the influenza diagnostic landscape.

    Regional Leadership: North America Takes the Lead
    Dominance in 2023
    In 2023, North America emerged as the largest region in the influenza diagnostic market. This regional dominance can be attributed to a robust healthcare infrastructure, technological advancements, and a proactive approach in adopting diagnostic solutions. As the market continues to evolve, North America remains a key player shaping the trajectory of influenza diagnostics.

    In conclusion, the influenza diagnostic market is on the cusp of significant growth, driven by the rise of rapid diagnostic tests, simultaneous detection solutions, strategic acquisitions, and a comprehensive understanding of market segmentation. With advancements in diagnostic technologies, the industry is poised to play a pivotal role in efficiently managing influenza and other respiratory illnesses in the years to come.

    Request for A Sample Of The Global Influenza Diagnostic Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=3237&type=smp